| Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis A Ruiz-Margáin, RU Macías-Rodríguez, J Ampuero, FJ Cubero, ... World journal of gastroenterology 22 (45), 10064, 2016 | 49 | 2016 |
| Sodium‐glucose cotransporter 2 inhibitors ameliorate ascites and peripheral edema in patients with cirrhosis and diabetes I Montalvo‐Gordon, LA Chi‐Cervera, G García‐Tsao Hepatology 72 (5), 1880-1882, 2020 | 37 | 2020 |
| Fibroblast growth factor 21 is an early predictor of acute‐on‐chronic liver failure in critically ill patients with cirrhosis A Ruiz‐Margáin, A Pohlmann, P Ryan, R Schierwagen, LA Chi‐Cervera, ... Liver Transplantation 24 (5), 595-605, 2018 | 33 | 2018 |
| Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study R Bernal-Reyes, ME Icaza-Chávez, LA Chi-Cervera, JM Remes-Troche, ... Revista de Gastroenterología de México (English Edition) 88 (3), 199-207, 2023 | 12 | 2023 |
| Is the Sars‐CoV‐2 virus a possible trigger agent for the development of achalasia? J Furuzawa‐Carballeda, ME Icaza‐Chávez, D Aguilar‐León, ... Neurogastroenterology & Motility 35 (3), e14502, 2023 | 11 | 2023 |
| Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease GAS Alvarez, SMP Galvez, UG Mora, ADC Contreras, CD Rosas, ... World Journal of Hepatology 14 (8), 1633, 2022 | 8 | 2022 |
| Prevalencia y características clínico-epidemiológicas de una población mexicana con enfermedad del hígado graso asociada a disfunción metabólica: un estudio en población abierta R Bernal-Reyes, ME Icaza-Chávez, LA Chi-Cervera, JM Remes-Troche, ... Revista de Gastroenterología de México 88 (3), 199-207, 2023 | 7 | 2023 |
| Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®) LA Chi-Cervera, GI Montalvo, ME Icaza-Chávez, J Torres-Romero, ... Journal of Medical Biochemistry 40 (1), 60, 2021 | 7 | 2021 |
| Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease N Méndez-Sánchez, A Valencia-Rodríguez, E Cerda-Reyes, ... European Journal of Gastroenterology & Hepatology 33 (1S), e824-e830, 2021 | 4 | 2021 |
| Increased incidence of and microbiologic changes in pyogenic liver abscesses in the Mexican population J Pérez-Escobar, W Ramirez-Quesada, DA Calle-Rodas, LA Chi-Cervera, ... World Journal of Hepatology 12 (10), 816, 2020 | 4 | 2020 |
| Body composition and phase angle by bioimpedance in patients with MAFLD SMP Gálvez, U García-Mora, GA Salgado-Álvarez, AD Cano-Contreras, ... Gastroenterología y Hepatología (English Edition) 45 (7), 535-542, 2022 | 2 | 2022 |
| Phase angle as an early nutritional marker of short-term outcome in hospitalized patients with cirrhosis A Ruiz-Margáin, R Macias-Rodriguez, L Chi-Cervera, S Rios-Torres, ... Journal of Hepatology 2 (64), S253, 2016 | 2 | 2016 |
| Análisis de la composición corporal y ángulo de fase por bioimpedancia en pacientes con MAFLD SMP Gálvez, U García-Mora, GA Salgado-Álvarez, AD Cano-Contreras, ... Gastroenterología y Hepatología 45 (7), 535-542, 2022 | 1 | 2022 |
| Long-standing cholecystectomy as a risk factor for advanced fibrosis in patients with non-alcoholic fatty liver disease: an observational multicenter study N Mendez-Sanchez, A Valencia-Rodriguez, E Cerda Reyes, ... HEPATOLOGY 72, 256A-256A, 2020 | 1 | 2020 |
| Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach O Mendez-Guerrero, A Carranza-Carrasco, LA Chi-Cervera, A Torre, ... World Journal of Gastroenterology 30 (10), 1313, 2024 | | 2024 |
| Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023 LE Munoz-Espinosa, A Torre, L Cisneros, I Montalvo-Gordon, ... Annals of Hepatology 29, 101472, 2024 | | 2024 |
| PROLONGED-RELEASE PIRFENIDONE IN PATIENTS WITH COMPENSATED CIRRHOSIS. FINAL RESULTS OF THE MULTICENTER STUDY ODISEA, CONTROLLED AGAINST PLACEBO, PLUS STANDARDIZED CARE LE Munoz-Espinosa, A Torre, L Cisneros, I Montalvo-Gordon, R Male, ... HEPATOLOGY 78, S1544-S1545, 2023 | | 2023 |
| WJH GAS Alvarez, SMP Galvez, UG Mora, AD Cano, CDR Contreras, ... World 14 (8), 1633-1642, 2022 | | 2022 |
| Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?(preprint) J Furuzawa-Carballeda, ME Icaza-Chavez, D Aguilar-Leon, ... | | 2022 |
| PROLONGED RELEASED PIRFENIDONE IN PATIENTS WITH ADVANCED LIVER FIBROSIS. INTERIM RESULTS OF A PLACEBO CONTROLLED MULTICENTER STUDY. LE Munoz-Espinosa, T Aldo, L Cisneros, I Montalvo-Gordon, R Male, ... HEPATOLOGY 74, 828A-829A, 2021 | | 2021 |
Osvely Mendez-GuerreroInvestigación, Instituto Nacional de Ciencias Medicas y Nutrición Salvador ZubiránVerified email at incmnsz.mx
